Quantcast

Latest Vaccines Stories

2014-06-18 16:26:28

Breaking New Ground in a Collective Search for Vaccines against Major Killer Diseases NEW YORK, June 18, 2014 /PRNewswire-USNewswire/ -- New technologies and insights in antigen discovery, genomics and immunological monitoring offer tremendous potential that could be collectively leveraged to speed development of vaccines against major diseases, according to leading scientists who met across specializations to explore creation of a Human Vaccines Project and reported their...

2014-06-18 08:29:32

TITUSVILLE, New Jersey, June 18, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen) announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A. VX-787 is an investigational medicine designed to directly inhibit replication of the influenza A virus, including recent H1...

2014-06-17 23:02:39

New research report “Human Papillomavirus Infections Vaccine Pipeline Analysis” drawn up by PNS Pharma is available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Human papillomaviruses represent a group of over 150 viruses which are related to each other, with certain types of viruses being able to cause warts (papillomas). There exist only two human papillomavirus vaccines which are currently marketed worldwide. Both these vaccines are prepared with the use of the...

2014-06-17 12:28:42

MERIDEN, Conn., June 17, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that BARDA, within the U.S. Department of Health and Human Services, exercised Option Period 2 of its contract with the Company (contract number HHS0100200900106C) to support development, scale-up and expanded licensure of the Company's influenza vaccines, Flublok® (seasonal) and Panblok® (pandemic). Option Period 2 has a budget of $50.6 million and will run through December 31, 2015. The...

2014-06-17 08:29:10

Submission follows receipt of Breakthrough Therapy designation in April 2014, highlighting unmet need for a licensed vaccine for serogroup B in the US(1) BASEL, Switzerland, June 17, 2014 /PRNewswire/ -- Novartis announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero(®) (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal...

2014-06-16 23:03:25

Transparency Market Research published a new report "Meningococcal Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html. Albany, New York (PRWEB) June 16, 2014 According to a new report published by Transparency Market Research "Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines,...

2014-06-16 16:25:10

AMES, Iowa, June 16, 2014 /PRNewswire/ -- Ames, Iowa-based vaccine producer, Harrisvaccines, today announced it has been granted United States Department of Agriculture (USDA) conditional licensure of the company's Porcine Epidemic Diarrhea Virus (PEDv) Vaccine, RNA utilizing its SirraVax(SM )RNA Particle Technology. This is the first USDA conditional license granted for a PEDv vaccine since the initial outbreak, and it will allow Harrisvaccines to sell their vaccine directly to the...

2014-06-16 12:29:42

LONDON, June 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Vaccine Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/cancer_vaccine_partnering_terms_agreements_1.html The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer vaccine partnering...

2014-06-16 09:40:01

Wolters Kluwer Health 'Education, awareness, and vaccination' are keys to fighting pertussis, says review in Journal of Christian Nursing Concerted effort is needed to reverse the ongoing rise in pertussis cases and deaths, especially among children and young people, according to the article by Emily Peake, APRN, MSN, FNP-C, CLC, and Lisa K. McGuire, MSN, MBA-HCM, RN. "This effort begins with nurses and nurse practitioners and other primary care providers who educate patients and the...

2014-06-16 08:29:05

First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Alere(TM) i Influenza A & B test, the first and only molecular test to detect and differentiate influenza A and B virus in less...


Latest Vaccines Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

45_cbb742ff010fcfbfac5b5b73fd2e0254
2011-02-23 17:23:51

Poliovirus, the causative agent of poliomyelitis and a member of the family of Picornaviridae, is a human enterovirus. It is composed of an RNA genome that is a single-stranded positive-sense RNA. It was first isolate in 1909 and was published in 1981. It is one of the most well characterized viruses and has become a useful model system for understanding the biology of RNA viruses. It infects human cells by binding to an immunoglobulin-like receptor on the cell surface. The three...

More Articles (2 articles) »
Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related